Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 25.62 is strong.
Medical Data Vision Co has a Altman Z-Score of 25.62, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Medical Data Vision Co's Altman Z-Score or its related term are showing as below:
TSE:3902'
s Altman Z-Score Range Over the Past 10 Years
Min: 7.57 Med: 25.51 Max: 59.38
Current: 25.62
During the past 13 years, Medical Data Vision Co's highest Altman Z-Score was 59.38. The lowest was 7.57. And the median was 25.51.
Medical Data Vision Co (TSE:3902) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Medical Data Vision Co Altman Z-Score Related Terms
Medical Data Vision Co Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Medical Data Vision Co's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3902 vs VEEV, TEM, BTSG: Altman Z-Score Comparison
For the Health Information Services subindustry, Medical Data Vision Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Medical Data Vision Co (TSE:3902) has a Altman Z-Score of 25.62 as of Aug. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Medical Data Vision Co and its competitors. This is near median its historical median of 25.51. Over the past decade, Medical Data Vision Co's Altman Z-Score has ranged from 7.57 to 59.38.
Is Medical Data Vision Co's Altman Z-Score too high?
Medical Data Vision Co's current Altman Z-Score of 25.62 is near median its 10-year median of 25.51. Over the past 10 years, this metric has ranged from a low of 7.57 to a high of 59.38. The Healthcare Providers & Services industry median Altman Z-Score is 2.43. Medical Data Vision Co's value of 25.62 is 954.3% above this industry median. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Altman Z-Score compare to VEEV and TEM?
Medical Data Vision Co's Altman Z-Score of 25.62 can be compared against companies in the Healthcare Providers & Services industry. The industry median Altman Z-Score is 2.43. Medical Data Vision Co's value of 25.62 is 954.3% above this benchmark. Historically, Medical Data Vision Co's own Altman Z-Score has ranged from 7.57 to 59.38 over the past decade. While the company's 10-year median is 25.51 vs. the industry median of 2.43, Medical Data Vision Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.43, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Data Vision Co's current Altman Z-Score of 25.62 is 954.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current Altman Z-Score is 25.62, which is near median its own 10-year median of 25.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Altman Z-Score of 25.62. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Altman Z-Score is 25.62, which is near median its 10-year median of 25.51 and 954.3% above the Healthcare Providers & Services industry median of 2.43. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Altman Z-Score is 25.62 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
Altman Z-Score: 25.62 (near median its 10-year median of 25.51)
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
Industry Position: 954.3% above the Healthcare Providers & Services median
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
